Medulloblastoma with Myogenic Differentiation: Long-term Survival in a Patient Treated with Aggressive Combination Therapy and Autologous Stem Cell Transplantation
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
Abstract
Medulloblastoma with myogenic differentiation (MMD) is a rare and aggressive variant of medulloblastoma, occurring predominantly in children. There have been only two case reports of long-term survival previously published. We report a case of long-term disease-free survival in a 21-year-old diagnosed with MMD.
References
1.
Lewis A
. Medulloblastoma with striated muscle fibers. Case report. J Neurosurg. 1973; 38(5):642-6.
DOI: 10.3171/jns.1973.38.5.0642.
View
2.
INGRAHAM F, Bailey O
. Cystic teratomas and teratoid tumors of the central nervous system in infancy and childhood. J Neurosurg. 2010; 3(6):511-32.
DOI: 10.3171/jns.1946.3.6.0511.
View
3.
Sachdeva M, Vankalakunti M, Rangan A, Radotra B, Chhabra R, Vasishta R
. The role of immunohistochemistry in medullomyoblastoma--a case series highlighting divergent differentiation. Diagn Pathol. 2008; 3:18.
PMC: 2391140.
DOI: 10.1186/1746-1596-3-18.
View
4.
Louis D, Ohgaki H, Wiestler O, Cavenee W, Burger P, Jouvet A
. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007; 114(2):97-109.
PMC: 1929165.
DOI: 10.1007/s00401-007-0243-4.
View
5.
Jaiswal A, Jaiswal S, Mahapatra A, Sharma M
. Unusually long survival in a case of medullomyoblastoma. J Clin Neurosci. 2005; 12(8):961-3.
DOI: 10.1016/j.jocn.2004.11.019.
View